The largest database of trusted experimental protocols

64 protocols using ifn γ fitc

1

Flow Cytometric Identification of Lymphocyte Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the identification of CD4+ Th cell subsets and CD8+ Tc cells, we used cytoplasmic cytokine staining method. Briefly, whole blood were diluted to 1:1 with saline solution and incubated with phorbol-12-myristate 13-acetate (PMA) (25 ng/ml), ionomycin (1 μg/ml) and Golgi Stop brefeldin A (10 μg/ml) (all from Sigma Aldrich, St. Louis, Missouri, USA) for 5 h at 37°C in 5% CO2 milieu. The following monoclonal antibodies were used for cell surface staining: CD4-PE-Cy5 or CD8-PE-Cy5 (both from Beckman Coulter). The cells were then fixed and permeabilized with Intraprep™ permeabilization reagent (Beckman Coulter) according to the manufacturer’s instructions, and intracellular cytokines were stained with the combination of interferon (IFN)-γ-FITC, interleukin (IL)-4-PE, IL-10-PE (all from BD Biosciences) and IL-17-PE (R&D Systems, Minneapolis, MN, USA) monoclonal antibodies. Measurements were performed and data were analyzed on Coulter FC500 flow cytometer (Beckman Coulter) equipped with Kaluza 1.2a software. IgG1-FITC (BD Biosciences) and IgG1-PE (R&D Systems) isotype-matched antibodies were used during the identification. Cells were quantified as their percentage in the CD4+ or CD8+ lymphocyte population.
+ Open protocol
+ Expand
2

Isolation and Activation of Naïve T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Hypaque density gradient centrifugation (Pharmacia LKB Biotechnology, Piscataway, NJ). Naïve T cells from PBMCs were isolated using a Miltenyi Biotec (Alburn, CA) negative selection kit. Purified naïve CD4+ T cells were activated with plate-bound anti-CD3 (5 μg/ml, BD Bioscience, San Jose CA), soluble anti-human CD28 (1 μg/ml, BD Bioscience), and IL-2 (20 ng/ml, R&D Systems) with or without FTY720 (100 ng/ml, Novartis). After 6 days, cell-free culture supernatants were collected for cytokine analysis by Luminex assay (Miltenyi Biotec), and cells were harvested for RNA extraction and intracellular staining. Naïve T cells were stimulated with PMA (Sigma), ionomycin (Sigma), and Golgistop for 4 h. Cells were stained for anti-human CD4 APC (BD Bioscience) and violet fluorescent reactive dye VVD (Life Technologies), and then cells were fixed and permeabilized with BD fixation and permeabilization buffer and stained for IFN-γ FITC and GZMB FITC (BD Bioscience). For surface staining, the following antibodies were used: anti-human CD4 pacific blue, anti-human CCR7 PE, and anti-human CD45RA APC, IgG2a PE isotype control, IgG2b, and k APC isotype control (all from BD Bioscience). All antibodies were titrated for flow cytometry, which was performed on a BD LSR II (BD Bioscience) and analyzed using Flowjo software.
+ Open protocol
+ Expand
3

Profiling Lung T Cell Activation and Cytokines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Activation and cytokine expression profiles of infiltrating T cells were investigated by fluorescence-activated cell-sorting (FACS) analysis. 1 × 106 lung T cells were stimulated with RSV-specific peptide (M282–90, 1 μM) (Anaspec, Fremont, CA) or PMA/Ionomycin (50 ng/mL and 1 μg/mL, respectively) for 6 h to assess CD8+ T-cell activation and CD4+ T-cell polarization, respectively. Fresh RPMI media without PMA/Ionomycin or M2 peptide was applied to cells as a negative control. Following the stimulation period, brefeldin A (0.5 ng/mL, BD Biosciences) was added to inhibit protein transport for 2 h before extracellular staining with rat anti-mouse CD8β eFlour 450 (clone: eBioH35-17.2) (eBioscience) hamster anti-mouse CD3ε APC-Cy7 (clone: 145-2C11), and rat anti-mouse CD4 PerCP-Cy5.5 (clone: RM4-5) (BD Biosciences). All cells were treated with cytofixation and permeabilization buffer (BD Biosciences) for 20 min prior to staining with rat anti-mouse IL-17A PE (clone: TC11-18H10.1), IFNγ FITC (clone: XMG1.2) and IL-4 APC (clone: 11B11) (BD Biosciences) for 45 min. Cells were washed two times with PBS containing 2% FBS and 0.1% NaN3 and analyzed on the FACS LSRII (BD Biosciences). At least 10,000 CD8+ events and 30,000 CD4+ events were acquired to ensure sufficient detection of intracellular IFNγ, IL-4, and IL-17A.
+ Open protocol
+ Expand
4

Tumor-Infiltrating Lymphocyte Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the in vitro tumor-cell challenge, 5–10×105 tumor-infiltrating lymphocytes (TIL), which were isolated from tumor tissues or lymphoid organs, were cultured with OVA peptide (1 µl/ml) for 4–5 hours in the presence of 1 µl/ml of Brefadin A (Sigma), washed and incubated with rat anti-mouse CD16/CD32 mAb (2.4G2) to block nonspecific binding, and then stained with CD8-PE-Cy5 and IFNγ-FITC or control antibodies according to the manufacturer’s instructions (BD Pharmingen). Tumor antigen-specific CD8 T cells were identified by staining with OVA-tetramer (Beckman Coulter) and TRP-2 pentamer (ProImmune). Cells were analyzed using FACScan flow cytometer and FlowJo version X.10 (Tree Star, Ashland, OR) software.
+ Open protocol
+ Expand
5

Cytokine and Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
IL-4 (BD555194), IL-10 (DY217b), IFN-γ (DY285), IL-13 (DY213), IL-17 (DY317), IL-22 (DY782), IL-26 (CSB-E11716h), rhIL-26 (R&D), rhIL-23 (R&D), rhIL-2 (R&D), Blocking mouse anti human HLA-Class I (W6/32) and anti-HLA-C (Abcam) both used at 10μg/ml, anti-MHC-II (MS163P1ABX) (Fisher), anti-IL-26 mAb1375, clone 197505 (R&D), CD4 (OKT4) (BD), IL-17PE (BD), IFN-γ- FITC (BD), CD14 FITC (BD) LL-37 (Innovagen). Mouse IgG1 and IgG2b isotype matched antibodies were used as controls.
+ Open protocol
+ Expand
6

CFSE Proliferation Assay with Cytokine Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CFSE staining was done using 5 µM CFSE (Invitrogen, Cat# C34554) as described by Parish et al. [42] (link) and stimulated with cytokines for 6 days prior to flow cytometric analysis. Antibodies used: CD8-APC (BD, Cat# 345775), CD3-APC (BD, Cat# 555335), CD4-APC (Biolegend, Cat# 300514), CD56-APC (eBioscience, Cat#17-0569-42), CD16-PE (Biolegend, Cat#302007), HLA-DR-PE (Biolegend, Cat# 307605), NKG2D-APC (RnD Systems, Cat# FAB139A). For intracellular staining, IL-6-PE (eBioscience, Cat#12-7069) and IFN-γ-FITC (BD, Cat# 554700) were used. Isotype controls were IgG1 APC (BD, cat # 555751), rat IgG1-PE (Invitrogen, Cat # R104) and IgG1-FITC (BD, Cat #555748). PBMCs were incubated for 6 h +/− LPS (Sigma-Aldrich, L2654, 1 µg/mL) and cells were stained using the BD Cytofix/Cytoperm Kit (BD, Cat# 554714), Golgistop (BD, Cat# 554724) or Golgiplug (BD, Cat# 555029) according to the manufacturer’s protocol. Samples were run on an Accuri C6 Flow cytometer and data were analyzed using FCS Express v. 3.
+ Open protocol
+ Expand
7

Multiparameter Flow Cytometry Analysis of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The remaining blood was used to isolate PBMCs using previously described methods [25] (link). PBMCs were thawed, washed and stained with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Invitrogen), and then stained with the following fluorescently-conjugated monoclonal antibodies: CD8-QDOT 605 and CD4-PE-Texas Red (Invitrogen, Grand Island, NY, USA); CD3-Pacific Blue, CCR5-PE-Cy5, CD38-PE, HLA-DR-FITC, PD-1 Alexa Fluor 647, CD45RA-PE-Cy7 (BD Biosciences, San Jose, CA, USA); and CCR7-APCeFluor 780 (eBioscience, San Diego, CA, USA). Naïve and memory T cell subsets were defined by quadrant gating with FMO controls on a CD45RA versus CCR7 plot.
For cytokine staining, PBMCs were stimulated for 18–22 h at 37°C with overlapping peptide pools corresponding to HIV-1 Con B Gag peptides (NIH 8117) in the presence of 0.5 µg/mL Brefeldin A and 05 µg/mL Monensin (Sigma-Aldrich, St. Louis, MO, USA). A control well with no stimulation was run in parallel for each sample. Cells were washed and stained with AARD, fixed, and permeabilized for intracellular staining with antibodies against CD3-Pacific Blue, IFNγ-FITC, IL-2-PE (BD BioSciences), CD4-PE Texas Red, and CD8-QDOT 605 (Invitrogen). Data were compensated and analyzed using FlowJo V9 (TreeStar, Ashland, OR, USA).
+ Open protocol
+ Expand
8

Multiparametric T cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cells were washed in staining buffer (SB) consisting of phosphate-buffered saline (PBS) containing 0.1% human serum albumin (HSA) and 0.1% sodium azide before staining for 20 min at RT. The cells were then washed in SB and fixed in SB containing 1% paraformaldehyd. For intracellular staining, T cells were stimulated for 6 h or overnight with APCs, loaded or not with p573, at a T-cell to target ratio of 1:2 and in the presence of BD GolgiPlug and BD Golgistop at a 1/1,000 dilution. Cells were stained both extracellular and intracellular using the PerFix-nc kit according to the manufacturer's instructions (Beckman Coulter Inc., USA). The following antibodies were used: Vβ3- FITC (Beckman Coulter-Immunotech SAS, France), CD3-eFluor450, CD4-eFluor 450, CD4-PE-Cy7, CD8-APC, CD8-eFluor 450, CD8-PE-Cy7, CD56-PE-Cy5.5 (BD Biosciences, USA) and CD107a-PE-Cy5 (BD Biosciences, USA), CXCR2-PE, IFNγ-FITC, IL-2-APC, TNF-α-PE (BD Biosciences, USA), CD261/TRAIL-R4-PE (BD Biosciences, USA). MART-1 (aa 26–35)-specific TCR was detected with dextramer staining (Immudex) following the manufacturer's recommendations. All antibodies were purchased from eBioscience, except where noted. Cells were acquired on a BD LSR II flow cytometer and the data analyzed using FlowJo software (Treestar Inc.).
+ Open protocol
+ Expand
9

Cytokine Profiling of T Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heparinized whole blood (100 μl) was cultured in 96 U bottom culture plate and incubated with PMA/Ionomycin (10 ng/ml and 100 µg/ml, Sigma-Aldrich, UK), P. falciparum 3D7 schizonts lysate (5 µg/ml) and mycobacterium purified protein derivative (10 µg/ml, Statens Serum Institut, Denmark) in parallel with a non-stimulated background control for 24 h. Harvested cells were stained with surface markersCD3-APC-H7, CD4-PerCP (all from BD Biosciences, San Jose, CA, USA), and CD8-Pacific Orange (Invitrogen™ Life technologies, Carlsbad, CA, USA) and lysed as above. The cells were the permeabilized with 500 μl of 1× BD Cytofix/Cytoperm (BD Cytofix/Cytoperm™, San Diego, California) and then stained with intracellular markers IFN-γ-FITC (BD FastImmune™, San Jose, CA, USA) and TNF-PE (BD Biosciences, San Jose, California) for 30 min. The cells were then acquired as above and minimum of 10,000 CD4+ T cell events were collected per sample. Single stained BD comp beads were processed and acquired in parallel to samples each day and used for compensation. Analysis was conducted using FlowJo software version 9.7.5 (Tree Star Inc., San Carlos, CA, USA).
+ Open protocol
+ Expand
10

MHC Tetramer-Based T-Cell Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
MHC class I tetramer was prepared in-house. Surface staining of T cells was achieved by addition of tetramer to whole blood, incubation for 10 minutes at room temperature, followed by addition of antibody co-stains for 20 minutes. Whole blood was preferred to thawed PBMCs for tetramer labelling due to greater consistency and signal intensity. Following lysis of erythrocytes using BD FACS Lysing solution (BD Biosciences), cells were either fixed using 2% formaldehyde (v/v) or permeabilized using the BD Cytofix/Cytoperm kit for intra-cellular staining. The following antibodies were used for surface and intra-cellular staining: CD3-PerCP, CD8-Horizon V500, CD8-APCH7, Ki-67-FITC, Bcl-2-PE, HLA-DR-Horizon V450, HLA-DR-PerCP, Perforin-FITC, Granzyme B-Horizon V450, CCR7-PE, CD27-Horizon V450, CD27-FITC, CD28-PECy7, CD28-PE (all BD Biosciences) and CD38-PECy7 (eBioscience), Granzyme B-PE (Caltag), Granzyme K-PE (Santa Cruz), CD45RA-FITC (Beckman Coulter), PD-1-PE and 2B4-PerCPCy5.5 (Biolegend). Intra-cellular cytokine staining with IFN-γ-FITC, TNF-α-APC, and IL-2-PerCpCy5.5 (all BD Biosciences) was undertaken after in vitro stimulation of PBMCs using peptide for 6 hours. Flow cytometry analysis was performed BD LSRII and BD FACSCanto flow cytometers. Flow cytometry data were analyzed using FlowJo software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!